GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomics Biopharma Ltd (ASX:BBM) » Definitions » Total Debt per Share

Biomics Biopharma (ASX:BBM) Total Debt per Share : A$0.00 (As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Biomics Biopharma Total Debt per Share?

A$0.00 (As of . 20)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Biomics Biopharma's Total Debt Per Share for the quarter that ended in . 20 was A$0.00.


Biomics Biopharma Total Debt per Share Historical Data

The historical data trend for Biomics Biopharma's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomics Biopharma Total Debt per Share Chart

Biomics Biopharma Annual Data
Trend
Total Debt per Share

Biomics Biopharma Semi-Annual Data
Total Debt per Share

Biomics Biopharma Total Debt per Share Calculation

Biomics Biopharma's Total Debt Per Share for the fiscal year that ended in . 20 is calculated as:

Biomics Biopharma's Total Debt Per Share for the quarter that ended in . 20 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biomics Biopharma Total Debt per Share Related Terms

Thank you for viewing the detailed overview of Biomics Biopharma's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomics Biopharma (ASX:BBM) Business Description

Traded in Other Exchanges
N/A
Address
1 Macquarie Place, Level 36, Gateway Tower, Sydney, NSW, AUS, 2000
Biomics Biopharma Ltd is a near-clinical-stage biopharmaceutical company in developing and commercialising double stranded ribonucleic acid (dsRNA) based innovative products for unmet medical needs.

Biomics Biopharma (ASX:BBM) Headlines

No Headlines